Eva Ados, ERshares COO and chief investment strategist, joins CNBC's 'Power Lunch' to share outlooks on three stocks.

TUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS) is awarding the ...

As Moderna (NASDAQ: MRNA) looks to shore up its business in the wake of its declining coronavirus vaccine sales, it's natural ...

Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight ...

The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready ...

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

Tesla stock rises even as President Donald Trump plans to roll back federal electric-vehicle production targets, Apple stock ...

The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.

Cryptocurrencies pulled back after President Trump didn't mention crypto in his inauguration address. Shares in MicroStrategy, which also disclosed it had [recently bought another $1.1 billion of bitc ...

President Trump rescinded an executive order that prompted the creation of three Medicare drug-pricing experiments ...